198 related articles for article (PubMed ID: 26878366)
1. Supported liquid extraction (SLE) for the analysis of methylamphetamine, methylenedioxymethylamphetamine and delta-9-tetrahydrocannabinol in oral fluid and blood of drivers.
Rositano J; Harpas P; Kostakis C; Scott T
Forensic Sci Int; 2016 Aug; 265():125-30. PubMed ID: 26878366
[TBL] [Abstract][Full Text] [Related]
2. The incidence of drugs of impairment in oral fluid from random roadside testing.
Chu M; Gerostamoulos D; Beyer J; Rodda L; Boorman M; Drummer OH
Forensic Sci Int; 2012 Feb; 215(1-3):28-31. PubMed ID: 21665392
[TBL] [Abstract][Full Text] [Related]
3. Drugs in oral fluid in randomly selected drivers.
Drummer OH; Gerostamoulos D; Chu M; Swann P; Boorman M; Cairns I
Forensic Sci Int; 2007 Aug; 170(2-3):105-10. PubMed ID: 17658711
[TBL] [Abstract][Full Text] [Related]
4. Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing.
Concheiro M; de Castro A; Quintela O; Cruz A; López-Rivadulla M
Forensic Sci Int; 2007 Aug; 170(2-3):156-62. PubMed ID: 17658709
[TBL] [Abstract][Full Text] [Related]
5. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
[TBL] [Abstract][Full Text] [Related]
6. Determination of 12 commonly found compounds in DUID cases in whole blood using fully automated supported liquid extraction and UHPLC-MS/MS.
Kristoffersen L; Langødegård M; Gaare KI; Amundsen I; Terland MN; Strand DH
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Sep; 1093-1094():8-23. PubMed ID: 29980102
[TBL] [Abstract][Full Text] [Related]
7. A rapid and sensitive method for the identification of delta-9-tetrahydrocannabinol in oral fluid by liquid chromatography-tandem mass spectrometry.
Molnar A; Lewis J; Doble P; Hansen G; Prolov T; Fu S
Forensic Sci Int; 2012 Feb; 215(1-3):92-6. PubMed ID: 21367546
[TBL] [Abstract][Full Text] [Related]
8. Negative-ion chemical ionization gas chromatography-mass spectrometry assay for enantioselective measurement of amphetamines in oral fluid: application to a controlled study with MDMA and driving under the influence cases.
Peters FT; Samyn N; Kraemer T; Riedel WJ; Maurer HH
Clin Chem; 2007 Apr; 53(4):702-10. PubMed ID: 17332148
[TBL] [Abstract][Full Text] [Related]
9. Trends in drivers testing positive for drugs of abuse in oral fluid from 2018 to 2021 in France.
Willeman T; Bartolli M; Jourdil JF; Vial S; Eysseric-Guérin H; Stanke-Labesque F
Forensic Sci Int; 2023 Nov; 352():111835. PubMed ID: 37748427
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of tetrahydrocannabinol isomers and other toxicologically relevant drugs in blood.
Mantinieks D; Di Rago M; Drummer OH; Glowacki L; Schumann J; Gerostamoulos D
Drug Test Anal; 2023 Dec; ():. PubMed ID: 38158877
[TBL] [Abstract][Full Text] [Related]
11. Driving under the influence of cannabis: pitfalls, validation, and quality control of a UPLC-MS/MS method for the quantification of tetrahydrocannabinol in oral fluid collected with StatSure, Quantisal, or Certus collector.
Wille SM; Di Fazio V; Ramírez-Fernandez Mdel M; Kummer N; Samyn N
Ther Drug Monit; 2013 Feb; 35(1):101-11. PubMed ID: 23318281
[TBL] [Abstract][Full Text] [Related]
12. Ultra-rapid targeted analysis of 40 drugs of abuse in oral fluid by LC-MS/MS using carbon-13 isotopes of methamphetamine and MDMA to reduce detector saturation.
Di Rago M; Chu M; Rodda LN; Jenkins E; Kotsos A; Gerostamoulos D
Anal Bioanal Chem; 2016 May; 408(14):3737-49. PubMed ID: 26993306
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of four oral fluid devices (DDS®, Drugtest 5000®, Drugwipe 5+® and RapidSTAT®) for on-site monitoring drugged driving in comparison with UHPLC-MS/MS analysis.
Strano-Rossi S; Castrignanò E; Anzillotti L; Serpelloni G; Mollica R; Tagliaro F; Pascali JP; di Stefano D; Sgalla R; Chiarotti M
Forensic Sci Int; 2012 Sep; 221(1-3):70-6. PubMed ID: 22554872
[TBL] [Abstract][Full Text] [Related]
14. The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC-MS/MS.
Molnar A; Fu S; Lewis J; Allsop DJ; Copeland J
Forensic Sci Int; 2014 May; 238():113-9. PubMed ID: 24699310
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of drugs in injured drivers.
Drummer OH; Kourtis I; Beyer J; Tayler P; Boorman M; Gerostamoulos D
Forensic Sci Int; 2012 Feb; 215(1-3):14-7. PubMed ID: 21377816
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of on-site oral fluid screening using Drugwipe-5(+), RapidSTAT and Drug Test 5000 for the detection of drugs of abuse in drivers.
Wille SM; Samyn N; Ramírez-Fernández Mdel M; De Boeck G
Forensic Sci Int; 2010 May; 198(1-3):2-6. PubMed ID: 19913376
[TBL] [Abstract][Full Text] [Related]
17. Correlation of Delta9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Dräger DrugTest.
Laloup M; Del Mar Ramirez Fernandez M; Wood M; De Boeck G; Maes V; Samyn N
Forensic Sci Int; 2006 Sep; 161(2-3):175-9. PubMed ID: 16842950
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of the Cozart DDS oral fluid collection device.
Speedy T; Baldwin D; Jowett G; Gallina M; Jehanli A
Forensic Sci Int; 2007 Aug; 170(2-3):117-20. PubMed ID: 17624706
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids determination in oral fluid by SPME-GC/MS and UHPLC-MS/MS and its application on suspected drivers.
Anzillotti L; Castrignanò E; Strano Rossi S; Chiarotti M
Sci Justice; 2014 Dec; 54(6):421-6. PubMed ID: 25498928
[TBL] [Abstract][Full Text] [Related]
20. The Victorian legislative framework for the random testing drivers at the roadside for the presence of illicit drugs: an evaluation of the characteristics of drivers detected from 2004 to 2006.
Boorman M; Owens K
Traffic Inj Prev; 2009 Mar; 10(1):16-22. PubMed ID: 19214873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
